and longitudinal NfL data Clene plans to analyze the APST ALS NfL biomarker and clinical dataset to compare NfL change from its ongoing NIH-sponsored EAP to address the FDA’s request for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback